# ResMed

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/resmed/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| OpenAlex ID | https://openalex.org/F4320317536 |
| Works | 1,557 |

## Funder papers

- [Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial](https://scholariq.org/papers/safety-and-tolerability-of-the-novel-non-steroidal-mineralocorticoid-receptor/)
- [A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease](https://scholariq.org/papers/a-randomized-controlled-study-of-finerenone-vs-eplerenone-in-patients-with/)
- [Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate](https://scholariq.org/papers/long-term-treatment-of-narcolepsy-and-idiopathic-hypersomnia-with-low-sodium/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.